Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
COVID-19 Pandemic and Cardiovascular Disease
Author(s): Aniket S Rali , Andrew J Sauer Added: 3 years ago
In late December 2019, an outbreak of an unknown disease called a pneumonia of uncertain cause occurred in Wuhan, Hubei Province, China.1 Over the next few days, several independent laboratories identified the causative agent as a novel coronavirus.2–4 The WHO has temporarily named this virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and the related infectious disease… View more

Vascular Disease and Surgery

Heart Failure
Cardiovascular Medical Education During the COVID-19 Pandemic
Author(s): Hilary Shapiro , Nosheen Reza Added: 2 years ago

COVID-19
Door-to-balloon Time in the COVID-19 Era
Author(s): Haytham Mously , Nischay Shah , Zachary Zuzek , et al Added: 2 years ago

COVID-19

MI/ACS
Job title: Visiting Professorial Fellow
Prof. Anderson is now recognised as the foremost expert Worldwide currently researching the structure and development of the normal and the congenitally malformed heart, with special emphasis on the disposition of the cardiac conduction tissues. Throughout his career, when he was based first at Royal Brompton Hospital, and subsequently at Great Ormond Street Children’s Hospital, all his studies… View more
ACC 2022 Late-breaker Discussion: The SuperWIN Trial
Author(s): Dylan L Steen , Harriette Van Spall Added: 2 years ago
Late-breaker host Dr Harriette Van Spall (McMaster University, CA) invites PI, Dr Dylan L Steen (University of Cincinnati College of Medicine, US) to discuss the SuperWIN trial (NCT03895580). The Supermarket and Web-based Intervention targeting Nutrition (SuperWIN) for cardiovascular risk reduction is a randomized controlled trial aimed at increasing diet quality and decreasing cardiovascular… View more

Prevention & Chronic Conditions
ESC 22: APOLLO: Apixaban for Prevention of Thromboembolic Outcomes in COVID
Author(s): Renato D Lopes Added: 1 year ago
ESC Congress 22 — Prof Renato Lopes (Duke University Medical Center, US) talks about the data from the APOLLO trial (NCT04746339). This randomized, double-blinded trial compared a DOAC, Apixaban 2.5 MG twice daily with placebo for 30 days. The trial assessed this intervention in outpatients with symptomatic SARS-CoV2 infection and risk factors for thrombosis. The primary outcome measure focused… View more

Anticoagulation

Vascular Disease and Surgery
Joerg Herrmann
Research Area(s) / Expertise:

Cardio-oncology

Atherosclerosis and Hyperlipidemia

 Job title: Director, Cardio-Oncology Clinic, Mayo Clinic, Rochester, US
Joerg Herrmann, M.D., is a cardiologist researching how cancer and heart disease interact. Dr. Herrmann's research focuses on cardio-oncology, which studies the potential negative effects of cancer treatments on the circulatory system. Additionally, Dr. Herrmann is very interested in vascular illnesses, particularly the formation of atherosclerotic plaques and their effects. His work also… View more
Job title: Director
Dr Marielle Scherrer-Crosbie is the Director of the Echocardiography Laboratory at the Hospital of the University of Pennsylvania, Philadelphia, Philadelphia, US. Her main research interests are in the use of imaging and biomarkers in cardio-oncology both in human populations and in small animal models. She also uses small animal models in studying subclinical cardiac dysfunction in metabolic… View more
TCT 22: Sentinel® Stroke Protection System During TAVR
Author(s): Samir R Kapadia Added: 1 year ago
TCT 22 - In this short interview, Dr Samir Kapadia (Cleveland Clinic, OH, US) outlines the findings of the PROTECTED-TAVR trial, which aimed to demonstrate the performance of Boston Scientific's Sentinel® Cerebral Protection System in transcatheter aortic valve replacement. In this study, 3000 patients were randomized to receive either TAVR with the Sentinel system or TAVR without intervention… View more

Prevention & Chronic Conditions

Intervention
Andrew Sauer
Research Area(s) / Expertise: Job title: Cardiologist
Dr Andrew J Sauer is a cardiologist at theUniversity of Kansas Medical Center in Kansas City, MO. He completed his medical studies at the University of Rochester and then received training at Massachusetts General Hospital and Northwestern University. His clinical interests include exploring rural healthcare disparities using remote monitoring and digital health technologies. Dr Andrew J Sauer… View more